105 results
6-K
EX-99.2
REPCF
RepliCel Life Sciences Inc.
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm
, and any fraud involving management or other employees who have a significant role in the Company's internal controls;
(bb) establish regular and separate … not be limited to, termination of a relationship for cause, violation of material Company policies, fraud, breach of non-competition, confidentiality
20-F/A
2021 FY
EX-12.1
REPCF
RepliCel Life Sciences Inc.
12 Sep 22
Annual report (foreign) (amended)
6:17pm
, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have
20-F/A
l78rcae3k0t9px
12 Sep 22
Annual report (foreign) (amended)
6:17pm
20-F/A
EX-12.2
7ivikqi6jt8m2 e7m
12 Sep 22
Annual report (foreign) (amended)
6:17pm
D
2m7jrzbfpto3g4
10 May 22
$592.73K in equity / options / securities to be acquired, sold $592.73K, 2 investors
3:57pm
D
96g3p91conkmujhg
20 Dec 21
$777.66K in equity, sold $777.66K, 1 investor
12:00am
6-K
EX-99.1
bqx0uyaz9xm7uhkwv3
18 Nov 21
Notice of Annual General and Special Meeting of Shareholders
10:36am
D/A
bvenbi
14 Jun 21
$161.52K in equity, sold $161.52K, 3 investors
11:46am
D
07qtycp7e
3 Jun 21
$111.57K in equity, sold $111.57K, 2 investors
5:03pm
D
npy2z7zv7jcf5vd73zdm
27 May 21
$9.01K in equity, sold $9.01K, 1 investor
12:22pm